Skip to Content
Merck
CN

118265

3-(p-Tolyl)propionic acid

98%

Sign In to View Organizational & Contract Pricing.

Select a Size


About This Item

Linear Formula:
CH3C6H4CH2CH2CO2H
CAS Number:
Molecular Weight:
164.20
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12352100
EC Number:
216-132-9
MDL number:
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

3-(p-Tolyl)propionic acid, 98%

InChI key

LDYGRLNSOKABMM-UHFFFAOYSA-N

InChI

1S/C10H12O2/c1-8-2-4-9(5-3-8)6-7-10(11)12/h2-5H,6-7H2,1H3,(H,11,12)

SMILES string

Cc1ccc(CCC(O)=O)cc1

assay

98%

form

solid

mp

115-118 °C (lit.)

functional group

carboxylic acid

Quality Level

Application

3-(p-Tolyl)propionic acid was used during the coupling of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide with 4,5-diphenyl-2-(2-p-tolyl-ethyl)-4,5-dihydro-1H-imidazole resin.

pictograms

Exclamation mark

signalword

Warning

Hazard Classifications

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

target_organs

Respiratory system

Storage Class

11 - Combustible Solids

wgk

WGK 3

ppe

dust mask type N95 (US), Eyeshields, Gloves

Regulatory Information

新产品
This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Gregory H Merriman et al.
Bioorganic & medicinal chemistry letters, 15(2), 435-438 (2004-12-18)
A series of 4,5-diarylimidazoline libraries were prepared using high-throughput solid-phase and microwave techniques. The compounds were evaluated as P2X(7) antagonists and their SAR is described.
Christopher S Wilson et al.
Chemistry (Weinheim an der Bergstrasse, Germany), 26(50), 11593-11603 (2020-06-11)
Dinuclear metallodrugs offer much potential in the development of novel anticancer chemotherapeutics as a result of the distinct interactions possible with bio-macromolecular targets and the unique biological activity that can result. Herein, we describe the development of isostructural homo-dinuclear OsII

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service